[{"address1": "P.O. Box 134", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "610 725 1500", "website": "https://www.galeratx.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and for patients with HNC undergoing standard-of-care radiotherapy. It also develops rucosopasem manganese (rucosopasem) to augment the anti-cancer efficacy of stereotactic body radiation therapy in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is based in Malvern, Pennsylvania.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Dr. J. Mel Sorensen M.D.", "age": 66, "title": "CEO, President & Director", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 632637, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Degnan", "age": 43, "title": "Chief Financial Officer", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 474045, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer Evans Stacey Esq.", "age": 58, "title": "Chief Legal & Compliance Officer and Secretary", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 8, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 8, "governanceEpochDate": 1719792000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.1342, "open": 0.12925, "dayLow": 0.1285, "dayHigh": 0.1425, "regularMarketPreviousClose": 0.1342, "regularMarketOpen": 0.12925, "regularMarketDayLow": 0.1285, "regularMarketDayHigh": 0.1425, "beta": 1.979, "forwardPE": -0.11491935, "volume": 85030, "regularMarketVolume": 85030, "averageVolume": 1342866, "averageVolume10days": 234000, "averageDailyVolume10Day": 234000, "bid": 0.1352, "ask": 0.1419, "marketCap": 7750888, "fiftyTwoWeekLow": 0.065, "fiftyTwoWeekHigh": 3.09, "fiftyDayAverage": 0.14918, "twoHundredDayAverage": 0.16905, "currency": "USD", "enterpriseValue": 146546880, "floatShares": 36237151, "sharesOutstanding": 54392200, "sharesShort": 2123783, "sharesShortPriorMonth": 2657537, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.039, "heldPercentInsiders": 0.36153, "heldPercentInstitutions": 0.18958999, "shortRatio": 1.16, "shortPercentOfFloat": 0.052800003, "bookValue": -2.476, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -45753000, "trailingEps": -0.91, "forwardEps": -1.24, "enterpriseToEbitda": -3.918, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "GRTX", "underlyingSymbol": "GRTX", "shortName": "Galera Therapeutics, Inc.", "longName": "Galera Therapeutics, Inc.", "firstTradeDateEpochUtc": 1573137000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "9ff241d9-e75a-35e9-b4be-f64d9dbab88e", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.1425, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 13466000, "totalCashPerShare": 0.248, "ebitda": -37399000, "totalDebt": 152262000, "quickRatio": 6.69, "currentRatio": 7.544, "returnOnAssets": -0.59294, "freeCashflow": -29474750, "operatingCashflow": -37973000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-14"}]